Oral contraceptive (OC) use and risk of breast cancer - reply

por Tryggvadóttir, L, Tulinius, H, Gudmundsdóttir, GB
Publicado 1997

The GSTT1 genotype is associated with p53 mutation status of breast cancer tumours

por Gudmundsdóttir, K, Tryggvadóttir, L, Eyfjörd, JE
Publicado 2000

CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status

por Gudmundsdottir, K, Thorlacius, S, Jonasson, J G, Sigfusson, B F, Tryggvadottir, L, Eyfjord, J E
Publicado 2003

Familial risks in nervous system tumours: joint Nordic study

por Hemminki, K, Tretli, S, Olsen, J H, Tryggvadottir, L, Pukkala, E, Sundquist, J, Granström, C
Publicado 2010

TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material.

por Gretarsdottir, S., Tryggvadottir, L., Jonasson, J. G., Sigurdsson, H., Olafsdottir, K., Agnarsson, B. A., Ogmundsdottir, H., Eyfjörd, J. E.
Publicado 1996

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

por Antoniou, A C, Cunningham, A P, Peto, J, Evans, D G, Lalloo, F, Narod, S A, Risch, H A, Eyfjord, J E, Hopper, J L, Southey, M C, Olsson, H, Johannsson, O, Borg, A, Passini, B, Radice, P, Manoukian, S, Eccles, D M, Tang, N, Olah, E, Anton-Culver, H, Warner, E, Lubinski, J, Gronwald, J, Gorski, B, Tryggvadottir, L, Syrjakoski, K, Kallioniemi, O-P, Eerola, H, Nevanlinna, H, Pharoah, P D P, Easton, D F
Publicado 2008

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

por Antoniou, A C, Cunningham, A P, Peto, J, Evans, D G, Lalloo, F, Narod, S A, Risch, H A, Eyfjord, J E, Hopper, J L, Southey, M C, Olsson, H, Johannsson, O, Borg, A, Pasini, B, Radice, P, Manoukian, S, Eccles, D M, Tang, N, Olah, E, Anton-Culver, H, Warner, E, Lubinski, J, Gronwald, J, Gorski, B, Tryggvadottir, L, Syrjakoski, K, Kallioniemi, O-P, Eerola, H, Nevanlinna, H, Pharoah, P D P, Easton, D F
Publicado 2008